Related Experiment Videos
Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis
L Leifeld1, J Ramakers, A M Schneiders
1Department of Internal Medicine I, University of Bonn, Sigmund Freud Strasse 25, D-53105 Bonn, Germany. l.leifeld@uni-bonn.de
Abstract:
Interferon-alpha (IFN-alpha) has potent pro-inflammatory and anti-viral functions. It exerts its effects by inducing intracellular proteins such as MxA. To analyse the role of intrahepatic interferon activation, IFN-alpha and MxA expression was studied by immunohistochemistry in explant livers of 20 patients with fulminant hepatic failure (FHF), 41 patients with chronic liver disease (CLD), and ten normal controls (NCs). In NCs only small numbers of Kupffer cells, but no hepatocytes, showed IFN-alpha and MxA expression. In contrast, significantly enhanced numbers of IFN-alpha- and MxA-positive Kupffer cells, along with small numbers of MxA-positive and larger numbers of IFN-alpha-positive lymphocytes, were found in CLD and in FHF. MxA protein was also expressed on hepatocytes and bile ducts in the vicinity of IFN-alpha-positive inflammatory infiltrates (hepatocytes: NCs: 0%, CLD: 8%, FHF: 68%; bile ducts: NCs: 19%, CLD: 46%, FHF: 83%). A significant correlation was found between the numbers of IFN-alpha- and MxA-positive cells (r=0.67, p<0.001). Thus, large amounts of IFN-alpha are released in the livers of patients with FHF, which is likely to contribute to immune-mediated liver cell damage. Intrahepatic MxA expression corresponds to IFN-alpha produced particularly by infiltrating inflammatory cells, rather than by hepatocytes themselves.
Insights
Interferon-alpha (IFN-alpha) is released in large amounts in fulminant hepatic failure (FHF) livers, contributing to immune-mediated damage. Intrahepatic MxA expression reflects this IFN-alpha, primarily from inflammatory cells.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Interferon-alpha (IFN-alpha) possesses significant pro-inflammatory and anti-viral properties.
- IFN-alpha mediates its effects through the induction of intracellular proteins, notably MxA.
- Understanding intrahepatic interferon activation is crucial for liver disease research.
Purpose of the Study:
- To investigate the expression patterns of IFN-alpha and MxA in explant livers from patients with fulminant hepatic failure (FHF), chronic liver disease (CLD), and normal controls (NCs).
- To determine the cellular sources of IFN-alpha and MxA within the liver microenvironment in different liver conditions.
Main Methods:
- Immunohistochemistry was employed to detect IFN-alpha and MxA expression.
- Analysis was performed on liver explants from 20 FHF patients, 41 CLD patients, and 10 NCs.
- Quantification of positive cells in Kupffer cells, lymphocytes, hepatocytes, and bile ducts was conducted.
Main Results:
- In normal controls, IFN-alpha and MxA expression was limited to a few Kupffer cells.
- CLD and FHF livers showed significantly increased numbers of IFN-alpha and MxA-positive Kupffer cells and lymphocytes.
- MxA and IFN-alpha expression was notably elevated in hepatocytes and bile ducts of FHF patients, correlating with nearby inflammatory infiltrates.
Conclusions:
- Substantial IFN-alpha release occurs in FHF livers, likely driving immune-mediated liver cell damage.
- Intrahepatic MxA expression is predominantly associated with IFN-alpha produced by infiltrating inflammatory cells, not hepatocytes.
- These findings highlight the role of interferon signaling in the pathogenesis of severe liver injury.